Product

Placebo inhalation solution

1 clinical trial

1 indication

Indication

Chronic Obstructive Pulmonary Disease

Clinical trial

A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study of Nebulized Revefenacin Inhalation Solution in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD).

Status: Completed, Estimated PCD: 2023-07-26